Tag: BNTX

1. BioNTech (BNTX -1.68%): BioNTech stock has fallen nearly 32% this year, mainly attributed to declining sales of their co-marketed COVID-19 vaccine, Comirnaty. In the first nine months of 2023, BioNTech’s total revenue was less than one-fifth of the prior year’s level. Despite this downturn, analysts are optimistic about BioNTech’s future. The average 12-month price […]